The European Medicines Agency (EMA) and the European Commission have published an information guide for healthcare professionals on biosimilar medicines.
Archive for Category: "Policies"

EBE, EFPIA and IFPMA have today launched a position paper entitled “Considerations for physicians on switching decisions regarding biosimilars”
